Homoeopathic treatment of increased blood uric acid

Effectiveness of individualized homoeopathic treatment and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014026

Enrollment

Registered

2018-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E799- Disorder of purine and pyrimidinemetabolism, unspecified

Interventions

Intervention1: Individualized homeopathic medicines plus Urtica urens mother tincture plus lifestyle modifications and dietary advices: Indicated homeopathic medicines in centesimal or fifty millesima

dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globule of poppy seed size (no. 10) shall be dissolved in 90 ml dist

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

be taken orally on clean tongue with empty stomach. Lifestyle modification will be advised in terms of encouraging to have lacto-vegetarian diet, restriction or moderation of high purine content food,

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from hyperuricemia, with or without gout 2. Age between 18 and 65 years 3. Patients with known but controlled systemic diseases with medication 4. Patients giving written consent to participate in the study 5. Literate patients; ability to read Bengali and/or English

Exclusion criteria

Exclusion criteria: 1. Secondary gout 2. Severe or advanced cases requiring surgical procedures or orthopedic corrections of deformities 3. Patients with psychiatric diseases 4. Cases suffering from uncontrolled systemic illness or life-threatening infections or any vital organ failure 5. Cases already undergoing homoeopathic treatment for any chronic disease 6. Substance abuse and/or dependence 7. Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
Serum uric acid levelTimepoint: Baseline, 3 months, 6 months	—

Secondary

Measure	Time frame
Gout Assessment Questionnaire 2 (GAQ2) translated Bengali versionTimepoint: Baseline, 3 months, 6 months;Measure Yourself Medical Outcome Profile (MYMOP) translated Bengali versionTimepoint: Baseline, 3 months, 6 months	—

Countries

India

Contacts

Public ContactHarcharanjeet Kaur

SGT University

dr.harcharan@gmail.com9810018876

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 17, 2026